MTOR and cancer: In addition to the mentioned small molecule inhibitors, dual PI3K/mTOR inhibitors such as GSK2126458, SF1126, LY294002, PF-04691502, LY302341, and PWT33597 have shown favorable antitumor efficacy in various malignant neoplasms [180].